FDA approves Cosette Pharmaceuticals' EVOXAC
Benzinga Newsdesk 1 week ago
FDANewsBiotechGeneral
– – New Oral Solution Formulation Developed for Patients Living with Sjögren’s Disease demonstrates Cosette's expanding capabilities in product development and innovation – –– – Product Expected to be Commercially
– – New Oral Solution Formulation Developed for Patients Living with Sjögren’s Disease demonstrates Cosette's expanding capabilities in product development and innovation – –
– – Product Expected to be Commercially Available by the end of 2026 – –